Radboud Translational Medicine

Radboud Translational Medicine (RTM) is a specialized radiopharmaceutical company based in Nijmegen, Netherlands, and is a subsidiary of the Radboud University Medical Center. The company operates a high-end cyclotron facility and GMP-certified radiopharmacy dedicated to the development and production of radioactive tracers for PET and SPECT imaging. RTM functions as a Contract Development and Manufacturing Organization (CDMO), supporting both academic researchers and pharmaceutical companies in bringing new diagnostic and therapeutic radiopharmaceuticals to clinical trials. Their core expertise lies in the translation of molecular imaging probes from preclinical research to human application, with a strong focus on oncology, neurology, and inflammatory diseases. By providing clinical-grade isotopes and labeled compounds, RTM plays a pivotal role in the advancement of personalized medicine and targeted radionuclide therapy.